SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 103 filers reported holding SCICLONE PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 1.45 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $1,873,000 | +1.7% | 167,178 | -0.1% | 0.00% | 0.0% |
Q2 2017 | $1,841,000 | +22.4% | 167,344 | +9.1% | 0.00% | – |
Q1 2017 | $1,504,000 | +4.5% | 153,430 | +15.1% | 0.00% | – |
Q4 2016 | $1,439,000 | -67.6% | 133,287 | -69.3% | 0.00% | -100.0% |
Q3 2016 | $4,446,000 | -65.0% | 433,789 | -55.4% | 0.00% | -60.0% |
Q2 2016 | $12,705,000 | +220.9% | 972,840 | +170.3% | 0.01% | +150.0% |
Q1 2016 | $3,959,000 | +62.0% | 359,941 | +35.5% | 0.00% | +100.0% |
Q4 2015 | $2,444,000 | +33.7% | 265,621 | +0.9% | 0.00% | 0.0% |
Q3 2015 | $1,828,000 | -24.1% | 263,310 | +7.3% | 0.00% | 0.0% |
Q2 2015 | $2,410,000 | +17.0% | 245,474 | +5.6% | 0.00% | 0.0% |
Q1 2015 | $2,060,000 | +69.8% | 232,513 | +68.0% | 0.00% | – |
Q4 2014 | $1,213,000 | +244.6% | 138,401 | +170.7% | 0.00% | – |
Q3 2014 | $352,000 | +87.2% | 51,123 | +43.0% | 0.00% | – |
Q2 2014 | $188,000 | +15.3% | 35,759 | 0.0% | 0.00% | – |
Q1 2014 | $163,000 | -59.2% | 35,759 | -55.0% | 0.00% | – |
Q4 2013 | $400,000 | +38.4% | 79,433 | +39.5% | 0.00% | – |
Q3 2013 | $289,000 | +100.7% | 56,934 | +95.6% | 0.00% | – |
Q2 2013 | $144,000 | – | 29,103 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Athos Capital Ltd | 284,200 | $3,126,000 | 1.80% |
Nine Chapters Capital Management LLC | 13,600 | $150,000 | 1.42% |
Stonepine Capital Management, LLC | 216,307 | $2,379,000 | 1.28% |
GLG Partners LP | 1,588,897 | $17,478,000 | 0.97% |
MENTA CAPITAL LLC | 431,996 | $4,752,000 | 0.56% |
Sapphire Star Partners LP | 24,834 | $273,000 | 0.34% |
Yakira Capital Management, Inc. | 85,500 | $941,000 | 0.28% |
TFS CAPITAL LLC | 55,104 | $606,000 | 0.24% |
BRANT POINT INVESTMENT MANAGEMENT LLC | 100,000 | $1,100,000 | 0.13% |
GABELLI & Co INVESTMENT ADVISERS, INC. | 102,261 | $1,125,000 | 0.12% |